Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
Main Authors: | Ibuki, Chikao, Seino, Yoshihiko, Otsuka, Toshiaki, Kimata, Nakahisa, Inami, Toru, Munakata, Ryo, Mizuno, Kyoichi |
---|---|
Format: | Online |
Language: | English |
Published: |
Elmer Press
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513420/ |
Similar Items
-
The Fixed-Dose Combination of Losartan/Hydrochlorothiazide Elicits Potent Blood Pressure Lowering During Nighttime in Obese Hypertensive Patients
by: Ibuki, Chikao, et al.
Published: (2014) -
Impact of Prediabetic Status on Coronary Atherosclerosis: A multivessel angioscopic study
by: Kurihara, Osamu, et al.
Published: (2013) -
Statins in cardiometabolic disease: what makes pitavastatin different?
by: Ginsberg, Henry
Published: (2013) -
Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus
by: Kawai, Yasuyuki, et al.
Published: (2011) -
Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
by: Nomura, Shosaku, et al.
Published: (2012)